
Investments
69Portfolio Exits
19Partners & Customers
10Service Providers
1About Boston Scientific
Boston Scientific (NYSE: BSX) develops and manufactures medical devices. It provides critical care products, electrophysiology products, gastroenterology products, pulmonology products, and more. The company offers pacemakers, defibrillators, coronary stents, and others. Boston Scientific caters to medical practitioners, patients, and research and development students. The company was founded in 1979 and is based in Marlborough, Massachusetts.

Want to inform investors similar to Boston Scientific about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Boston Scientific
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Boston Scientific in 2 Expert Collections, including Fortune 500 Investor list.
Fortune 500 Investor list
590 items
This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.
Medical Devices
4,328 items
https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.
Research containing Boston Scientific
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Boston Scientific in 4 CB Insights research briefs, most recently on Feb 21, 2022.


Dec 17, 2020
5 Ways Digital Twins Could Improve HealthcareLatest Boston Scientific News
Jan 26, 2023
News provided by Share this article Share this article NEW YORK, Jan. 26, 2023 /PRNewswire/ -- The Remote Patient Monitoring Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 22.22% and register an incremental growth of USD 1,733.81 million during the forecast period. The report provides a comprehensive analysis on growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF Sample Report Regional Analysis Technavio has announced its latest market research report titled Global Remote Patient Monitoring Market 2023-2027 By region, the global remote patient monitoring market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 46% of the market's growth during the forecast period. The growing awareness of the benefits of remote patient monitoring solutions, increasing work pressure across healthcare facilities, growing advances in patient data collection technologies, and the rising prevalence of chronic diseases are driving the growth of the regional market. Company Profiles The remote patient monitoring market report includes information on the key products and recent developments of leading vendors, including: Abbott Laboratories: The company offers remote patient monitoring such as FreeStyle LibreLink App, and LibreView. Advantech Co. Ltd: The company offers remote patient monitoring such as Advantech POC 6 series Boston Scientific Corp: The company offers remote patient monitoring such as LATITUDE NXT Patient Management System. Draegerwerk AG and Co. KGaA: The company offers remote patient monitoring such as Infinity PiCCO SmartPod, and Infinity M540. Honeywell International Inc: The company offers remote patient monitoring such as the CARESCAPE ONE system. Koninklijke Philips NV Market Dynamics The market is driven by factors such as the cost benefits of remote patient monitoring, the emergence of digital healthcare services and healthcare 4.0, and the need for healthcare facilities in remote areas. However, the complexities associated with the deployment of smart healthcare solutions are hindering market growth. Competitive Analysis The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample Market Segmentation By product, the market is segmented into vital signs and implantable. The vital signs segment accounted for the largest share of the market during the forecast period. By geography, the market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America held the largest share of the market during the forecast period. Related Reports: Patient Monitoring Equipment Market in Japan by Product and End-user - Forecast and Analysis 2022-2026: The patient monitoring equipment market share in Japan is expected to increase by USD 366.62 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.79%. The growing preference for self-care monitoring devices is notably driving the patient monitoring equipment market growth in Japan, although factors such as data privacy issues may impede the market growth. Laboratory Shaker Market by Product, Application, and Geography - Forecast and Analysis 2023-2027: The laboratory shaker market is estimated to grow at a CAGR of 7.09% between 2022 and 2027. The size of the market is forecast to increase by USD 611.28 million. The increased use of laboratory shakers in various applications is notably driving the market growth, although factors such as the high cost of laboratory shakers may impede the market growth. Key companies profiled Abbott Laboratories, Advantech Co. Ltd., Alten SA, Boston Scientific Corp., Caretaker Medical NA, Draegerwerk AG and Co. KGaA, Honeywell International Inc., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, MphRx Inc., Napier Healthcare Solutions Pte Ltd., Nihon Kohden Corp., OMRON Corp., OSI Systems Inc., OSP Labs, Shenzhen Mindray BioMedical Electronics, Siemens AG, Smiths Group Plc, and General Electric Co. Market dynamics Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Browse for Technavio " Health Care " Research Reports Table of Contents Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global remote patient monitoring market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on Global remote patient monitoring market 2017 - 2021 ($ million) 4.2 Product Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million) 4.3 End user Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size – End user Segment 2017 - 2021 ($ million) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million) 5 Five Forces Analysis Exhibit 33: Data Table on Comparison by Product 6.3 Vital signs - Market size and forecast 2022-2027 Exhibit 34: Chart on Vital signs - Market size and forecast 2022-2027 ($ million) Exhibit 35: Data Table on Vital signs - Market size and forecast 2022-2027 ($ million) Exhibit 36: Chart on Vital signs - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Vital signs - Year-over-year growth 2022-2027 (%) 6.4 Implantable - Market size and forecast 2022-2027 Exhibit 38: Chart on Implantable - Market size and forecast 2022-2027 ($ million) Exhibit 39: Data Table on Implantable - Market size and forecast 2022-2027 ($ million) Exhibit 40: Chart on Implantable - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Implantable - Year-over-year growth 2022-2027 (%) 6.5 Market opportunity by Product Exhibit 42: Market opportunity by Product ($ million) 7 Market Segmentation by End-user 7.1 Market segments Exhibit 46: Data Table on Comparison by End-user 7.3 Hospitals - Market size and forecast 2022-2027 Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) 7.4 ASCs - Market size and forecast 2022-2027 Exhibit 51: Chart on ASCs - Market size and forecast 2022-2027 ($ million) Exhibit 52: Data Table on ASCs - Market size and forecast 2022-2027 ($ million) Exhibit 53: Chart on ASCs - Year-over-year growth 2022-2027 (%) Exhibit 54: Data Table on ASCs - Year-over-year growth 2022-2027 (%) 7.5 Home care - Market size and forecast 2022-2027 Exhibit 55: Chart on Home care - Market size and forecast 2022-2027 ($ million) Exhibit 56: Data Table on Home care - Market size and forecast 2022-2027 ($ million) Exhibit 57: Chart on Home care - Year-over-year growth 2022-2027 (%) Exhibit 58: Data Table on Home care - Year-over-year growth 2022-2027 (%) 7.6 Market opportunity by End-user Exhibit 59: Market opportunity by End-user ($ million) 8 Customer Landscape Exhibit 64: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 China - Market size and forecast 2022-2027 Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%) 9.9 Germany - Market size and forecast 2022-2027 Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.10 Canada - Market size and forecast 2022-2027 Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%) 9.11 UK - Market size and forecast 2022-2027 Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 101: Market opportunity by geography ($ million) 10 Drivers, Challenges, and Trends 10.1 Market drivers Exhibit 102: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11.3 Landscape disruption 11.4 Industry risks About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact
Boston Scientific Investments
69 Investments
Boston Scientific has made 69 investments. Their latest investment was in SetPoint Medical as part of their Series F on January 1, 2023.

Boston Scientific Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
1/19/2023 | Series F | SetPoint Medical | $80M | No | Action Potential Venture Capital, Ascendum Capital, Boston Scientific, Catalio Capital Management, Citta Capital, Euclidean Capital, Gilmartin Capital, Midas Capital, Morgenthaler Ventures, New Enterprise Associates, Norwest Venture Partners, Richard King Mellon Foundation, Shangbay Capital, SVE Capital, Topspin Fund, Undisclosed Investors, and Viking Global Investors | 4 |
9/1/2021 | Series C | Nectero Medical | $19.5M | Yes | 9 | |
8/4/2021 | Series A | Append Medical | $7.4M | Yes | Boston Scientific, Intellectual Ventures, Israel Innovation Authority, MedTecX, MEDX Ventures Group, and Undisclosed Investors | 5 |
3/5/2021 | Corporate Minority | |||||
9/21/2020 | Corporate Minority - II |
Date | 1/19/2023 | 9/1/2021 | 8/4/2021 | 3/5/2021 | 9/21/2020 |
---|---|---|---|---|---|
Round | Series F | Series C | Series A | Corporate Minority | Corporate Minority - II |
Company | SetPoint Medical | Nectero Medical | Append Medical | ||
Amount | $80M | $19.5M | $7.4M | ||
New? | No | Yes | Yes | ||
Co-Investors | Action Potential Venture Capital, Ascendum Capital, Boston Scientific, Catalio Capital Management, Citta Capital, Euclidean Capital, Gilmartin Capital, Midas Capital, Morgenthaler Ventures, New Enterprise Associates, Norwest Venture Partners, Richard King Mellon Foundation, Shangbay Capital, SVE Capital, Topspin Fund, Undisclosed Investors, and Viking Global Investors | Boston Scientific, Intellectual Ventures, Israel Innovation Authority, MedTecX, MEDX Ventures Group, and Undisclosed Investors | |||
Sources | 4 | 9 | 5 |
Boston Scientific Portfolio Exits
19 Portfolio Exits
Boston Scientific has 19 portfolio exits. Their latest portfolio exit was RenovoRx on August 26, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
8/26/2021 | IPO | Public | 7 | ||
12/7/2020 | Acq - Fin | 1 | |||
5/12/2020 | Divestiture | Boston Scientific - Intrauterine Health Product Line | 1 | ||
Date | 8/26/2021 | 12/7/2020 | 5/12/2020 | ||
---|---|---|---|---|---|
Exit | IPO | Acq - Fin | Divestiture | ||
Companies | Boston Scientific - Intrauterine Health Product Line | ||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 7 | 1 | 1 |
Boston Scientific Acquisitions
59 Acquisitions
Boston Scientific acquired 59 companies. Their latest acquisition was Acotec on December 11, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
12/11/2022 | Other Venture Capital | Corporate Majority | 12 | |||
11/29/2022 | Debt | $184.07M | Acq - Pending | 1 | ||
8/15/2022 | Seed / Angel | $3.23M | Acquired | 11 | ||
6/15/2022 | ||||||
6/15/2022 |
Date | 12/11/2022 | 11/29/2022 | 8/15/2022 | 6/15/2022 | 6/15/2022 |
---|---|---|---|---|---|
Investment Stage | Other Venture Capital | Debt | Seed / Angel | ||
Companies | |||||
Valuation | |||||
Total Funding | $184.07M | $3.23M | |||
Note | Corporate Majority | Acq - Pending | Acquired | ||
Sources | 12 | 1 | 11 |
Boston Scientific Partners & Customers
10 Partners and customers
Boston Scientific has 10 strategic partners and customers. Boston Scientific recently partnered with Truveta on September 9, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
9/27/2022 | Licensor | United States | Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data The partnership will enable Boston Scientific researchers to access Truveta 's de-identified data from more than 65 million U.S. patients , with the aim of gathering insights into devices and disease states . | 4 | |
8/16/2022 | Partner | United States | Earlier this year , GE Healthcare signed a similar partnership with Boston Scientific in Southeast Asia which also offers combined cardiology solutions to customers including in training and education . | 2 | |
5/24/2022 | Partner | United States | The Urology Care Foundation announces Medical Student Innovation Fellowship in collaboration with Boston Scientific Corporation . | 1 | |
1/5/2022 | Partner | ||||
1/1/2022 | Partner |
Date | 9/27/2022 | 8/16/2022 | 5/24/2022 | 1/5/2022 | 1/1/2022 |
---|---|---|---|---|---|
Type | Licensor | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data The partnership will enable Boston Scientific researchers to access Truveta 's de-identified data from more than 65 million U.S. patients , with the aim of gathering insights into devices and disease states . | Earlier this year , GE Healthcare signed a similar partnership with Boston Scientific in Southeast Asia which also offers combined cardiology solutions to customers including in training and education . | The Urology Care Foundation announces Medical Student Innovation Fellowship in collaboration with Boston Scientific Corporation . | ||
Sources | 4 | 2 | 1 |
Boston Scientific Service Providers
1 Service Provider
Boston Scientific has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Acquired | Investment Bank | Financial Advisor |
Service Provider | |
---|---|
Associated Rounds | Acquired |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Boston Scientific Team
69 Team Members
Boston Scientific has 69 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
John Abele | Kingbridge | Founder | Current |
Name | John Abele | ||||
---|---|---|---|---|---|
Work History | Kingbridge | ||||
Title | Founder | ||||
Status | Current |
Compare Boston Scientific to Competitors
Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.

Saluda Medical is a global medical device company developing a platform of closed-loop neuromodulation technologies, based on the neural response to stimulation, to aid people suffering from chronic back pain and other debilitating conditions. The company's first device is the Evoke Spinal Cord Stimulation (SCS) System, a closed-loop SCS that is currently being evaluated in a randomized, double-blinded clinical trial.

Nuvaira is a privately held company headquartered in Minneapolis, MN. The company’s proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The Nuvaira Lung Denervation System is under clinical investigation and is not commercially available in the USA, and is CE Mark approved.

Cardionomic addresses Acute Decompensated Heart Failure's root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality.
ShiraTronics develops an approach to treat migraine headaches. The company is focused on developing and clinically testing its neuromodulation technology

Lungpacer Medical develops a therapeutic solution for preserving or restoring the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation. The Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach. Through this approach, the company seeks to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. The company was founded in 2009 and is based in Vancouver, British Columbia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.